| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc. | Chief Executive Officer, Director | Common Shares | 55,192 | $256,091 | $4.64 | 23 Aug 2023 | Direct |
| DURECT CORP | Director | Common Stock | 0 | $0 | $1.90 | 11 Sep 2025 | Direct |
| ProMIS Neurosciences Inc. | Chief Executive Officer, Director | Warrants to purchase Common Shares | 53,192 | 23 Aug 2023 | Direct | ||
| AVROBIO, Inc. | Director | Stock Option (Right to Buy) | 17,643 | 06 Jun 2023 | Direct | ||
| DURECT CORP | Director | Stock Option (right to buy) | 0 | 11 Sep 2025 | Direct | ||
| ZOGENIX, INC. | EVP & Chief Development Officer | Common Stock | 0 | $26.04 | 07 Mar 2022 | Direct | |
| ZOGENIX, INC. | EVP & Chief Development Officer | Restricted Stock Units | 0 | 07 Mar 2022 | Direct | ||
| ZOGENIX, INC. | EVP & Chief Development Officer | Stock Option (Right to Buy) | 0 | $26.09 | 07 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DRRX | DURECT CORP | 11 Sep 2025 | 6 | $0 | 4 | Director | 12 Sep 2025, 20:20 |
| DRRX | DURECT CORP | 10 Sep 2025 | 2 | +$6,710 | 4 | Director | 11 Sep 2025, 18:00 |
| DRRX | DURECT CORP | 25 Sep 2024 | 1 | $0 | 4 | Director | 27 Sep 2024, 16:17 |
| PMN | ProMIS Neurosciences Inc. | 23 Aug 2023 | 2 | $0 | 4 | Chief Executive Officer, Director | 25 Aug 2023, 16:19 |
| DRRX | DURECT CORP | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 17:31 |
| TECX | AVROBIO, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 16:28 |
| PMN | ProMIS Neurosciences Inc. | 14 Dec 2022 | 1 | +$4,940 | 4 | Chief Executive Officer | 16 Dec 2022, 14:30 |
| PMN | ProMIS Neurosciences Inc. | 06 Dec 2022 | 1 | +$5,700 | 4 | Chief Executive Officer | 08 Dec 2022, 16:24 |
| PMN | ProMIS Neurosciences Inc. | 19 Sep 2022 | 1 | $0 | 4 | Chief Executive Officer | 20 Sep 2022, 16:57 |
| PMN | ProMIS Neurosciences Inc. | 19 Sep 2022 | 0 | $0 | 3 | Chief Executive Officer | 20 Sep 2022, 16:52 |
| DRRX | DURECT CORP | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:09 |
| TECX | AVROBIO, Inc. | 08 Jun 2022 | 2 | $0 | 4 | Director | 10 Jun 2022, 16:39 |
| DRRX | DURECT CORP | 16 May 2022 | 2 | +$22,012 | 4 | Director | 18 May 2022, 20:35 |
| DRRX | DURECT CORP | 11 May 2022 | 3 | +$8,258 | 4 | Director | 13 May 2022, 21:07 |
| DRRX | DURECT CORP | 10 May 2022 | 1 | +$950 | 4 | Director | 12 May 2022, 20:32 |
| DRRX | DURECT CORP | 09 May 2022 | 2 | +$8,584 | 4 | Director | 10 May 2022, 21:12 |
| /report/000089924322010301-farfel-gail-m-2022-03-07 | ZOGENIX, INC. | 07 Mar 2022 | 8 | $0 | 4 | EVP & Chief Development Officer | 09 Mar 2022, 18:10 |
| DRRX | DURECT CORP | 15 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 16:32 |
| TECX | AVROBIO, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 17:47 |